ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹100 Cr | ₹92 Cr | ₹46 Cr | ₹-1.95 Cr | ₹-117 Cr |
What is the latest Consolidated Net Profit of ORCHID PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹-1.95 Cr |
| Mar2021 | ₹-117 Cr |
How is Consolidated Net Profit of ORCHID PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 8.13 | |
| Mar2024 | ₹92 Cr | 98.99 | |
| Mar2023 | ₹46 Cr | Positive | |
| Mar2022 | ₹-1.95 Cr | Negative | |
| Mar2021 | ₹-117 Cr | - | |
Compare Consolidated Net Profit of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,181.3 Cr | -7.1% | 4.1% | 45.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -7.1% |
4.1% |
45.5% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses